Mindset Pharma Inc.
7Patents
7Active
7Granted
58Portfolio score
Filing activity: Jul 28, 2021 → May 30, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11591353B2 | Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Physics | 4 | Active |
| US11427604B2 | Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Physics | 2 | Active |
| US11597738B2 | Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Physics | 2 | Active |
| US12378266B2 | Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Physics | 0 | Active |
| US11453689B2 | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Chemistry; Metallurgy | 0 | Active |
| US12054504B2 | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Chemistry; Metallurgy | 0 | Active |
| US12054505B2 | Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.